Non-invasive brain stimulation and neuroenhancement.
Clin Neurophysiol Pract
; 7: 146-165, 2022.
Article
en En
| MEDLINE
| ID: mdl-35734582
AD, Alzheimer's Disease; BDNF, brain derived neurotrophic factor; Cognitive enhancement; DARPA, Defense Advanced Research Projects Agency; DIY stimulation; DIY, Do-It-Yourself; DLPFC, dorsolateral prefrontal cortex; EEG, electroencephalography; EMG, electromyography; FCC, Federal Communications Commission; FDA, (U.S.) Food and Drug Administration; Home-stimulation; IFCN, International Federation of Clinical Neurophysiology; LTD, long-term depression; LTP, long-term potentiation; MCI, mild cognitive impairment; MDD, Medical Device Directive; MDR, Medical Device Regulation; MEP, motor evoked potential; MRI, magnetic resonance imaging; NIBS, noninvasive brain stimulation; Neuroenhancement; OTC, Over-The-Counter; PAS, paired associative stimulation; PET, positron emission tomography; PPC, posterior parietal cortex; QPS, quadripulse stimulation; RMT, resting motor threshold; SAE, serious adverse event; SMA, supplementary motor cortex; TBS, theta-burst stimulation; TMS, transcranial magnetic stimulation; Transcranial brain stimulation; rTMS, repetitive transcranial magnetic stimulation; tACS; tACS, transcranial alternating current stimulation; tDCS; tDCS, transcranial direct current stimulation; tES, transcranial electric stimulation; tRNS, transcranial random noise stimulation
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Guideline
/
Prognostic_studies
Idioma:
En
Revista:
Clin Neurophysiol Pract
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania